← Back to Search

Patient Navigation for Non-Small Cell Lung Cancer

N/A

Waitlist Available

Led By David Gerber

Research Sponsored by University of Texas Southwestern Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 years

Awards & highlights

Study Summary

This trial will test if patient navigation, or help getting services and info, reduces the number of people who don't get needed lung cancer screenings.

Eligible Conditions

Non-Small Cell Lung Cancer
Compliance Behavior
Prevention of Harmful Effects

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of Completion

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Usual Care + Patient NavigationExperimental Treatment1 Intervention

Participants will experience standard practice for lung cancer early detection plus the intervention.

Group II: Usual CareActive Control1 Intervention

Participants will experience standard practice for lung cancer early detection.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Patient Navigation

2017

Completed Phase 2

~38910

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor

1,048 Previous Clinical Trials

1,053,328 Total Patients Enrolled

Cancer Prevention Research Institute of TexasOTHER

50 Previous Clinical Trials

97,991 Total Patients Enrolled

David GerberPrincipal InvestigatorUniversity of Texas Southwestern Medical Center

1 Previous Clinical Trials

168 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment to this experiment still possible for participants?

"According to the data posted on clinicaltrials.gov, this study is not actively enrolling participants at present. This project was launched on June 16th 2017 and its most recent update was registered on March 30th 2022. Despite this trial's current inactivity, there are 1530 other medical trials that have open recruitment windows right now."

Answered by AI

Does this research involve participants of a more advanced age?

"According to the official criteria, only those aged between 55 and 74 can take part in this trial. As for younger patients, there are 28 trials available for them; on the other hand, 1528 studies are designed for senior citizens."

Answered by AI

Who are the most suitable candidates for this investigation?

"To qualify, prospective participants must be aged between 55 and 74 years old and suffer from non-small cell lung carcinoma (nsclc). This medical trial is looking to enrol 446 subjects."

Answered by AI

Recent research and studies

Contemporary Clinical TrialsJournal

Patient Navigation for Lung Cancer Screening in an Urban Safety-net System: Protocol for a Pragmatic Randomized Clinical Trial

Gerber, David E., Heidi A. Hamann, Noel O. Santini, Suhny Abbara, Hsienchang Chiu, Molly McGuire, Lisa Quirk, Hong Zhu, and Simon J. Craddock Lee. 2017. “Patient Navigation for Lung Cancer Screening in an Urban Safety-net System: Protocol for a Pragmatic Randomized Clinical Trial”. Contemporary Clinical Trials. Elsevier BV. doi:10.1016/j.cct.2017.07.003.

clinicaltrials.govStudy

Patient Navigation for Lung Cancer Screening in an Urban Safety-Net System

David E Gerber 2017. "Patient Navigation for Lung Cancer Screening in an Urban Safety-Net System". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02758054.